The Effect of Low-Dose Inhaled Budesonide on Pc₂₀ Amp Levels in Patients with Mild Asthma: A 3-Month Follow-Up Study

References

• Holgate S T. Pathogenesis of asthma. Clin Exp Allergy 2008; 38: 872–897
   PubMed Web of Science ®Google Scholar
• Doull I JM, Sandall D, Smith S, Schreiber J, Freezer N J, Holgate S T. Differential inhibitory effect of regular inhaled corticosteroid on airway responsiveness to adenosine 5′ monophosphate, methacholine, and bradykinin in symptomatic children with recurrent wheeze. Pediatr Pulmonol 1997; 23: 404–411
   PubMedGoogle Scholar
• NHLBI/WHO Workshop Report. Global Strategy for asthma management and prevention: Global Initiative for Asthma. National Institutes of Health. 2002, Publication Number 02-3659
   Google Scholar
• Spicuzza L, Di Maria G, Polosa R. Adenosine in the airways: Implications and applications. Eur J Pharmacol 2006; 533: 77–88
   PubMed Web of Science ®Google Scholar
• Finney M JB, Karlson J A, Persson C GA. Effect of bronchoconstrictors and bronchodilators on a novel human small airway preparation. Br J Pharmacol 1985; 85: 29–36
   PubMed Web of Science ®Google Scholar
• Cursley M J, Tattersfield A E, Holgate S T. Inhaled adenosine, guanosine 5′ monophosphate (AMP) on airway caliber in normal and asthmatic subjects. Br J Clin Pharmacol 1983; 15: 161–165
   PubMedGoogle Scholar
• Mann J S, Holgate S T, Renwick A G, Cushley M J. Airway effects of purine nucleosides and nucleotides and release with bronchial provocation in asthma. J Appl Physiol 1986; 61: 1667–1676
   PubMedGoogle Scholar
• Driver A G, Kukoly C A, Ali S, Mustafa S J. Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis 1993; 148: 91–97
   PubMed Web of Science ®Google Scholar
• Huszar E, Vass G, Vizi E, Csoma Z, Barat E, Molnar Vilagos G, Herjavecz I, Horvath I. Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma. Eur Respir J 2002; 20: 1393–1398
   PubMed Web of Science ®Google Scholar
• Van D en, Berge M, Kerstjens H A, De Reus D M, Koeter G H, Kauffman H F, Postma D S. Provocation with adenosine 5′-monophosphate, but not methacholine, induces sputum eosinophilia. Clin Exp Allergy 2004; 34: 71–76
   PubMedGoogle Scholar
• De Meer G, Heederik D, Postma D S. Bronchial responsiveness to adenosine 5′–monophosphate (AMP) and methacholine differ in their relationship with airway allergy and baseline FEV1. Am J Respir Crit Care Med 2002; 165: 327–331
   PubMed Web of Science ®Google Scholar
• Van D en, Toorn L M, Prins J B, Overbeek S E, Hoogsteden H C, de Jongste J C. Adolescents in clinical remission of atopic asthma have elevated exhaled nitric oxide levels and bronchial hyperresponsiveness. Am J Respir Crit Care Med 2000; 162: 953–957
   PubMedGoogle Scholar
• Polosa R, Ciamarra I, Mangano G, Prosperini G, Pistorio M P, Vancheri C, Crimi N. Bronchial hyperresponsiveness and airway inflammation markers in nonasthmatics with allergic rhinitis. Eur Respir J 2000; 15: 30–35
   PubMed Web of Science ®Google Scholar
• Avital A, Springer C, Bar-Yishay E, Godfrey S. Adenosine, methacholine and exercise challenges in children with asthma or pediatric chronic obstructive pulmonary disease. Thorax 1995; 50: 511–516
   PubMed Web of Science ®Google Scholar
• Benckhuijsen J, Van Den Bos J W, Van Velzen E, de Bruijn R, Aalbers R. Differences in the effect of allergen avoidance on bronchial hyperresponsiveness as measured by methacholine, adenosine 5′ monophosphate, and exercise in asthmatic children. Pediatr Pulmonol 1996; 22: 147–153
   PubMed Web of Science ®Google Scholar
• Prieto L, Bruno L, Gutierrez V, Uixera S, Perez-Frances C, Lnuza A, Ferrer A. Airway Responsiveness to adenosine 5′-monophosphate and exhaled nitric oxide measurements. Chest 2003; 124: 1325–1333
   PubMedGoogle Scholar
• Spicuzza L, Polosa R. The role of adenosine as a novel bronchoprovocant in asthma. Curr Opin Allergy Clin Immunol 2003; 3: 65–69
   PubMedGoogle Scholar
• Phillips G D, Holgate S T. The effect of oral terfenadine alone and in combination with flurbiprofen on the bronchoconstrictor response to inhaled adenosine 5′-monophosphate in nonatopic asthma. Am Rev Respir Dis 1989; 139: 463–469
   PubMedGoogle Scholar
• Rorke S, Jennison S, Jeffs J A, Sampson A P, Arshad H, Holgate S T. Role of cysteinyl leukotrienes in adenosine 5′-monophosphate induced bronchoconstriction in asthma. Thorax 2002; 57: 323–327
   PubMedGoogle Scholar
• Van D en, Berge M, Kerstjens H AM, Meijer R J, De Reus D M, Koeter G H, Kauffman H F, Postma D S. Corticosteroid-induced improvement in the PC 20 of adenosine monophosphate is more closely associated with reduction in airway inflammation than improvement in the PC 20 of methacholine. Am J Respir Crit Care Med 2001; 164: 1127–1132
   PubMedGoogle Scholar
• Prosperini G, Rajakulasingam K, Cacciola R R, Spicuzza L, Rorke S, Holgate S T, Di Maria G U, Polosa R. Changes in sputum counts and airway hyperresponsiveness after budesonide: Monitoring anti-inflammatory response on the basis of surrogate markers of airway inflammation. J Allergy Clin Immunol 2002; 110: 855–861
   PubMedGoogle Scholar
• Luijk B, Kempsford R D, Wright A M, Zanen P, Lammers J WJ. Duration of effect of single dose inhaled fluticasone propionate on AMP–induced bronchoconstriction. Eur Respir J 2004; 23: 559–564
   PubMed Web of Science ®Google Scholar
• Bousquet J, Van Cauwenberge P, Khaltaev N. ARIA Workshop group: World Health Organization. J Allergy Clin Immunol 2001; 108: S147–334
   PubMed Web of Science ®Google Scholar
• Quanjer P H, Tammeling G J, Cotes J E, Pedersen O F, Peslin R, Yernault J C. Lung volumes and forced ventilator flows. Report of the Working Party on Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16: 5–40
   PubMedGoogle Scholar
• Crapo R O, Casaburi R, Coates A L, Enright P L, Hankinson J L, Irvin C G, MacIntyre N R, McKay R T, Wanger J S, Anderson S D, Cockcroft D W, Fish J E, Sterk P J. Guidelines for methacholine and exercise challenge testing–1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000; 161: 309–329
   PubMed Web of Science ®Google Scholar
• Chai H, Farr R S, Froehlich L A, Mathison D A, McLean J A, Rosenthal R R, Sheffer A L, Spector S L, Townley R G. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975; 56: 323–327
   PubMed Web of Science ®Google Scholar
• Cockcroft D W, Murdock K Y, Mink J T. Determination of histamine PC 20: Comparison of linear and logarithmic interpolation. Chest 1983; 84: 505–506
   PubMed Web of Science ®Google Scholar
• Ribeiro M, Pereira C AC, Nevy L E, Beppu O S, Silva C OS. Methacholine vs. adenosine on intra and extrathoracic airway hyperresponsiveness in patients with cough variant asthma. Allergy 2008; 63: 527–532
   PubMedGoogle Scholar
• Fowler S J, Dempsey O J, Sims E J, Lipworth B J. Screening for bronchial hyperresponsiveness using methacholine and adenosine monophosphate. Relationship to asthma severity and beta (2)-receptor genotype. Am J Respir Crit Care Med 2000; 162: 1318–1322
   PubMed Web of Science ®Google Scholar
• Meijer R J, Kerstjens H AM, Arends L R, Kauffman H F, Koeter G H, Postma D S. Effects of inhaled fluticasone and oral prednisolone on clinical and inflammatory parameters in patients with asthma. Thorax 1999; 54: 894–899
   PubMed Web of Science ®Google Scholar
• Ketchell R I, Jensen M W, Lumley P, Wright A M, Allenby M I, O'Connor B J. Rapid effect of inhaled fluticasone propionate on airway responsiveness to adenosine 5′-monophosphate in mild asthma. J Allergy Clin Immunol 2002; 110: 603–606
   PubMed Web of Science ®Google Scholar
• O'Connor B J, Ridge S M, Barnes P J, Fuller R W. Greater effect of inhaled budesonide on adenosine 5 monophosphate induced than on sodium metabisulfite induced bronchoconstriction in asthma. Am Rev Respir Dis 1992; 146: 560–564
   PubMed Web of Science ®Google Scholar
• Van D en, Berge M, Kerstjens H AM, Postma D S. Provocation with adenosine 5′ monophosphate as a marker of inflammation in asthma, allergic rhinitis and chronic obstructive pulmonary disease. Clin Exp Allergy 2002; 32: 824–830
   PubMedGoogle Scholar
• Zhao Y, Leung P C, Woo K S, Chen G G, Wong Y O, Liu S X, van Hasselt C A. Inhibitory effects of budesonide, desloratadine and dexamethasone on cytokine release from human mast cell line (HMC-1). Inflamm Res 2004; 53: 664–669
   PubMedGoogle Scholar
• Versluis M, Postma D S, Timens W, Hylkema M N. Effects of IL-4 and IL-13 on adenosine receptor expression and responsiveness of the human mast cell line 1. Int Immunopharmacol 2008; 8: 866–873
   PubMedGoogle Scholar
• Wilson A M, Lipworth B J. Dose–response evaluation of the therapeutic index for inhaled budesonide in patients with mild-to-moderate asthma. Am J Med 2000; 108: 269–275
   PubMed Web of Science ®Google Scholar
• Taylor D A, Jensen M W, Kanabar V, Engelstätter R, Steinijans V W, Barnes P J, O'Connor B J. A dose–dependent effect of the novel inhaled corticosteroid ciclesonide on airway responsiveness to adenosine-5-monophosphate in asthmatic patients. Am J Respir Crit Care Med 1999; 160: 237–243
   PubMed Web of Science ®Google Scholar
• Holgate S T, Arshad H, Stryszak P, Harrison J E. Mometasone furoate antagonizes AMP-induced bronchoconstriction in patients with mild asthma. J Allergy Clin Immunol 2000; 105: 906–911
   PubMedGoogle Scholar
• Van D en, Berge M, Meijer R J, Kerstjens H AM, de Reus D M, Koeter G H, Kauffman H F, Postma D S. PC20Adenosine 5′-Monophosphate is more closely associated with airway inflammation in asthma than PC20 Methacholine. Am J Respir Crit Care Med 2001; 163: 1146–1150
   Google Scholar
• Chalmers G W, Macleod K J, Little S A, Thomson L J, McSharry C P, Thomson N C. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax 2002; 57: 226–230
   PubMed Web of Science ®Google Scholar
• Tomlinson J EM, McMahon A D, Chaudhuri R, Thompson J M, Wood S F, Thomson N C. Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax 2005; 60: 282–287
   PubMed Web of Science ®Google Scholar
• Piccillo G, Caponnetto P, Barton S, Russo C, Origlio A, Bonaccorsi A, Di Maria A, Oliveri C, Polosa R. Changes in airway hyperresponsiveness following smoking cessation: Comparisons between Mch and AMP. Respir Med 2008; 102: 256–265
   PubMed Web of Science ®Google Scholar
• Halterman J S, Szilagyi P G, Yoos L, Conn K M, Kaczorowski J M, Holzhauer R J, Lauver S C, Neely T L, Callahan P M, McConnochie K M. Benefits of a school-based asthma treatment program in the absence of secondhand smoke exposure. Arch Pediatr Adolesc Med 2004; 158: 460–467
   PubMed Web of Science ®Google Scholar